122 related articles for article (PubMed ID: 30463098)
1. Cucurbitacin B Induces Hypermethylation of Oncogenes in Breast Cancer Cells.
Dittharot K; Dakeng S; Suebsakwong P; Suksamrarn A; Patmasiriwat P; Promkan M
Planta Med; 2019 Mar; 85(5):370-378. PubMed ID: 30463098
[TBL] [Abstract][Full Text] [Related]
2. Cucurbitacin B inhibits human breast cancer cell proliferation through disruption of microtubule polymerization and nucleophosmin/B23 translocation.
Duangmano S; Sae-Lim P; Suksamrarn A; Domann FE; Patmasiriwat P
BMC Complement Altern Med; 2012 Oct; 12():185. PubMed ID: 23062075
[TBL] [Abstract][Full Text] [Related]
3. Antiproliferative effects of cucurbitacin B in breast cancer cells: down-regulation of the c-Myc/hTERT/telomerase pathway and obstruction of the cell cycle.
Duangmano S; Dakeng S; Jiratchariyakul W; Suksamrarn A; Smith DR; Patmasiriwat P
Int J Mol Sci; 2010; 11(12):5323-38. PubMed ID: 21614210
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of Wnt signaling by cucurbitacin B in breast cancer cells: reduction of Wnt-associated proteins and reduced translocation of galectin-3-mediated β-catenin to the nucleus.
Dakeng S; Duangmano S; Jiratchariyakul W; U-Pratya Y; Bögler O; Patmasiriwat P
J Cell Biochem; 2012 Jan; 113(1):49-60. PubMed ID: 21866566
[TBL] [Abstract][Full Text] [Related]
5. ERα propelled aberrant global DNA hypermethylation by activating the DNMT1 gene to enhance anticancer drug resistance in human breast cancer cells.
Si X; Liu Y; Lv J; Ding H; Zhang XA; Shao L; Yang N; Cheng H; Sun L; Zhu D; Yang Y; Li A; Han X; Sun Y
Oncotarget; 2016 Apr; 7(15):20966-80. PubMed ID: 26980709
[TBL] [Abstract][Full Text] [Related]
6. Cytotoxic properties of root extract and fruit juice of Trichosanthes cucumerina.
Kongtun S; Jiratchariyakul W; Kummalue T; Tan-ariya P; Kunnachak S; Frahm AW
Planta Med; 2009 Jun; 75(8):839-42. PubMed ID: 19288406
[TBL] [Abstract][Full Text] [Related]
7. Higenamine enhances the antitumor effects of cucurbitacin B in breast cancer by inhibiting the interaction of AKT and CDK2.
Jin ZQ; Hao J; Yang X; He JH; Liang J; Yuan JW; Mao Y; Liu D; Cao R; Wu XZ; Li X; Chen D
Oncol Rep; 2018 Oct; 40(4):2127-2136. PubMed ID: 30106443
[TBL] [Abstract][Full Text] [Related]
8. 3,6-Dihydroxyflavone regulates microRNA-34a through DNA methylation.
Peng X; Chang H; Chen J; Zhang Q; Yu X; Mi M
BMC Cancer; 2017 Sep; 17(1):619. PubMed ID: 28870206
[TBL] [Abstract][Full Text] [Related]
9. Cucurbitacin B markedly inhibits growth and rapidly affects the cytoskeleton in glioblastoma multiforme.
Yin D; Wakimoto N; Xing H; Lu D; Huynh T; Wang X; Black KL; Koeffler HP
Int J Cancer; 2008 Sep; 123(6):1364-75. PubMed ID: 18561312
[TBL] [Abstract][Full Text] [Related]
10. The effectiveness of cucurbitacin B in BRCA1 defective breast cancer cells.
Promkan M; Dakeng S; Chakrabarty S; Bögler O; Patmasiriwat P
PLoS One; 2013; 8(2):e55732. PubMed ID: 23393598
[TBL] [Abstract][Full Text] [Related]
11. Scrophularia Atropatana Extract Reverses TP53 Gene Promoter Hypermethylation and Decreases Survivin Antiapoptotic Gene Expression in Breast Cancer Cells.
Ghavifekr Fakhr M; Rezaie Kahkhaie K; Shanehbandi D; Farshdousti Hagh M; Zarredar H; Safarzadeh E; Abdolrahimi Vind M; Baradaran B
Asian Pac J Cancer Prev; 2018 Sep; 19(9):2599-2605. PubMed ID: 30256066
[TBL] [Abstract][Full Text] [Related]
12. Cucurbitacin B inhibits the translational expression of hypoxia-inducible factor-1α.
Ma J; Zi Jiang Y; Shi H; Mi C; Li J; Xing Nan J; Wu X; Joon Lee J; Jin X
Eur J Pharmacol; 2014 Jan; 723():46-54. PubMed ID: 24333213
[TBL] [Abstract][Full Text] [Related]
13. Emodin induces cytotoxic effect in human breast carcinoma MCF-7 cell through modulating the expression of apoptosis-related genes.
Li WY; Chan RY; Yu PH; Chan SW
Pharm Biol; 2013 Sep; 51(9):1175-81. PubMed ID: 23763280
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of DNMT1 and ERRα crosstalk suppresses breast cancer via derepression of IRF4.
Vernier M; McGuirk S; Dufour CR; Wan L; Audet-Walsh E; St-Pierre J; Giguère V
Oncogene; 2020 Oct; 39(41):6406-6420. PubMed ID: 32855526
[TBL] [Abstract][Full Text] [Related]
15. Epigenetic CRBP downregulation appears to be an evolutionarily conserved (human and mouse) and oncogene-specific phenomenon in breast cancer.
Arapshian A; Bertran S; Kuppumbatti YS; Nakajo S; Mira-y-Lopez R
Mol Cancer; 2004 Apr; 3():13. PubMed ID: 15113415
[TBL] [Abstract][Full Text] [Related]
16. 23,24-Dihydrocucurbitacin B induces G2/M cell-cycle arrest and mitochondria-dependent apoptosis in human breast cancer cells (Bcap37).
Yang L; Wu S; Zhang Q; Liu F; Wu P
Cancer Lett; 2007 Oct; 256(2):267-78. PubMed ID: 17681423
[TBL] [Abstract][Full Text] [Related]
17. Piwi-interacting RNA-651 promotes cell proliferation and migration and inhibits apoptosis in breast cancer by facilitating DNMT1-mediated PTEN promoter methylation.
Liu T; Wang J; Sun L; Li M; He X; Jiang J; Zhou Q
Cell Cycle; 2021 Aug; 20(16):1603-1616. PubMed ID: 34313525
[TBL] [Abstract][Full Text] [Related]
18. Homeobox protein MSX1 inhibits the growth and metastasis of breast cancer cells and is frequently silenced by promoter methylation.
Yue Y; Yuan Y; Li L; Fan J; Li C; Peng W; Ren G
Int J Mol Med; 2018 May; 41(5):2986-2996. PubMed ID: 29436596
[TBL] [Abstract][Full Text] [Related]
19. Cucurbitacin D induces cell cycle arrest and apoptosis by inhibiting STAT3 and NF-κB signaling in doxorubicin-resistant human breast carcinoma (MCF7/ADR) cells.
Ku JM; Kim SR; Hong SH; Choi HS; Seo HS; Shin YC; Ko SG
Mol Cell Biochem; 2015 Nov; 409(1-2):33-43. PubMed ID: 26169986
[TBL] [Abstract][Full Text] [Related]
20. Genome-wide profiling in melatonin-exposed human breast cancer cell lines identifies differentially methylated genes involved in the anticancer effect of melatonin.
Lee SE; Kim SJ; Yoon HJ; Yu SY; Yang H; Jeong SI; Hwang SY; Park CS; Park YS
J Pineal Res; 2013 Jan; 54(1):80-8. PubMed ID: 22856590
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
